Chemomab Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update

August 12, 2024

https://www.globenewswire.com/news-release/2024/08/12/2928254/0/en/Chemomab-Therapeutics-to-Report-Second-Quarter-2024-Financial-Results-and-Provide-a-Business-Update.html

TEL AVIV, Israel, Aug. 12, 2024 (GLOBE NEWSWIRE) — Chemomab Therapeutics Ltd. (Nasdaq:CMMB) (“Chemomab” or the “Company”), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced the company will issue a press release reporting its second quarter 2024 financial results and providing a business update on August 21, 2024, at 7:00 am Eastern Time.  

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.